TBIO News and Press, Translate Bio Inc. From 02/23/24

2024-02-23 08:44:16 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Telesis Bio (NASDAQ: TBIO ) stock is on the rise Friday as the synthetic biology company’s shares experienced heavy trading this morning. Shares of TBIO stock are off...

2024-02-23 07:30:39 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning! Moving socks this morning are earnings reports, a mo...

2024-01-22 07:42:32 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips We’re starting the trading week with a breakdown of the biggest pre-market stock movers worth knowing about on Monday! Moving shares this morning are insider selling, special meeting...

2023-11-13 17:22:29 ET More on Telesis Bio Telesis Bio appoints William Kullback as CFO Seeking Alpha’s Quant Rating on Telesis Bio Historical earnings data for Telesis Bio Financial information for Telesis Bio For further details see: Tele...

SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today reported financial results for the third quarter of 2023. “This quarter, we continued to drive adoption of our instruments and kits, m...

INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...

Telesis Bio Inc. (TBIO) is expected to report $-0.28 for Q3 2023

SAN DIEGO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its third quarter 2023 financial results on Monday, November 13, 2023, after the market closes. The press r...

SAN DIEGO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp® De novo Cloning and Amplification kit on the BioXp 3250 and BioXp 9600 systems . This cell-...

SAN DIEGO, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp® NGS Library Prep kit for Whole Genome Sequencing on the BioXp 3250 and BioXp 9600 systems ...